Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.

Hill A, Garratt A, Levi J, Falconer J, Ellis L, McCann K, Pilkington V, Qavi A, Wang J, Wentzel H

DOI: 10.1093/ofid/ofab358
Published: 2021 Nov
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofab358,
  title = {Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.},
  author = {Hill A and Garratt A and Levi J and Falconer J and Ellis L and McCann K and Pilkington V and Qavi A and Wang J and Wentzel H},
  year = {2021},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofab358},
  url = {https://doi.org/10.1093/ofid/ofab358}
}

RIS

TY  - JOUR
TI  - Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
AU  - Hill A
AU  - Garratt A
AU  - Levi J
AU  - Falconer J
AU  - Ellis L
AU  - McCann K
AU  - Pilkington V
AU  - Qavi A
AU  - Wang J
AU  - Wentzel H
PY  - 2021
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofab358
UR  - https://doi.org/10.1093/ofid/ofab358
ER  -

APA

A, H., A, G., J, L., J, F., L, E., K, M., V, P., A, Q., J, W., & H, W. (2021). Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofab358

Source records

pubmed · retrieved 2026-09-24T22:09:46.462Z
europe-pmc · retrieved 2026-09-24T22:09:46.506Z